The Emirates Drug Establishment has initiated a precautionary recall of select Nestlé infant formula batches across the UAE due to potential Bacillus cereus contamination, reinforcing its commitment to public health and consumer safety.
The Emirates Drug Establishment (EDE) has announced a precautionary recall of specific batches of Nestlé-branded infant formula products from markets across the UAE. The measure has been taken due to the potential presence of traces of Bacillus cereus, as part of ongoing efforts to safeguard public health and ensure community safety.
Also Read: UAE Introduces Tiered Excise Tax on Sweetened Beverages
The Authority stated that the recall is a preventive step aimed at minimizing any potential health risks, particularly to infants. Members of the public have been urged to remain vigilant and to report any related cases or concerns through the designated reporting channel at [email protected]
The Emirates Drug Establishment reaffirmed its commitment to monitoring product safety, enforcing regulatory compliance, and taking timely action to protect consumers and maintain confidence in the UAE’s healthcare and pharmaceutical systems.
